4.7 Review

Adverse Impact of Environmental Chemicals on Developmental Origins of Kidney Disease and Hypertension

Journal

FRONTIERS IN ENDOCRINOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2021.745716

Keywords

chronic kidney disease; hypertension; DOHaD (developmental origins of health and disease); environmental chemical; oxidative stress; endocrine disruption chemical; renin-angiotensin system

Funding

  1. Chang Gung Memorial Hospital, Kaohsiung, Taiwan [CMRPG8J0253, CORPG8L0301, CORPG8L0261, CORPG8L0121]

Ask authors/readers for more resources

To reduce the global burden of kidney disease and hypertension, urgent action is needed to identify toxic chemicals in the environment, avoid harmful chemical exposure during pregnancy and lactation, and translate effective reprogramming interventions from animal studies into clinical practice.
Chronic kidney disease (CKD) and hypertension are becoming a global health challenge, despite developments in pharmacotherapy. Both diseases can begin in early life by so-called developmental origins of health and disease (DOHaD). Environmental chemical exposure during pregnancy can affect kidney development, resulting in renal programming. Here, we focus on environmental chemicals that pregnant mothers are likely to be exposed, including dioxins, bisphenol A (BPA), phthalates, per- and polyfluoroalkyl substances (PFAS), polycyclic aromatic hydrocarbons (PAH), heavy metals, and air pollution. We summarize current human evidence and animal models that supports the link between prenatal exposure to environmental chemicals and developmental origins of kidney disease and hypertension, with an emphasis on common mechanisms. These include oxidative stress, renin-angiotensin system, reduced nephron numbers, and aryl hydrocarbon receptor signaling pathway. Urgent action is required to identify toxic chemicals in the environment, avoid harmful chemicals exposure during pregnancy and lactation, and continue to discover other potentially harmful chemicals. Innovation is also needed to identify kidney disease and hypertension in the earliest stage, as well as translating effective reprogramming interventions from animal studies into clinical practice. Toward DOHaD approach, prohibiting toxic chemical exposure and better understanding of underlying mechanisms, we have the potential to reduce global burden of kidney disease and hypertension.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available